Now I have all the information I need. Let me write the consolidated review.

---

## Summary

This paper introduces ComputAgeBench, a standardized benchmarking framework for evaluating blood-based epigenetic aging clocks. The authors define explicit criteria for selecting aging-accelerating conditions (AACs), collect and harmonize 66 public DNA methylation datasets covering 19 conditions across 9 disease classes, and propose four evaluation tasks (relative age acceleration -- AA2, absolute age acceleration -- AA1, chronological age prediction accuracy, and prediction bias) together with a cumulative benchmarking score. Thirteen published clock models are evaluated, with results showing second-generation (mortality-trained) clocks like PhenoAgeV2 and GrimAge variants outperforming first-generation clocks on aging-acceleration detection.

## Strengths

1. **Principled, evidence-based criteria for condition and dataset selection.** Sections 3.1–3.2 lay out three explicit criteria for AACs (decreased life expectancy, chronic, systemic) and five criteria for dataset inclusion (open access, BSB samples, age resolution, microarray platform, minimum sample sizes). This formalizes a selection pipeline absent in prior comparative work and directly addresses the lack of standardization documented in Section 2.2.

2. **Unprecedented scale of harmonized public data.** The benchmark aggregates 66 datasets from more than 50 published studies, covering 19 conditions across 9 disease classes (Section 3.3, Figure 2E). This is substantially larger than prior comparisons (e.g., Ying et al. 2024; Liu et al. 2020) and forms a reusable resource for the community.

3. **Cumulative score that explicitly addresses positive model bias.** Equation (2) defines a score that penalizes the AA1 task contribution when a model exhibits systematic positive bias, directly addressing the known confound that positive bias can inflate apparent aging-acceleration detection. The paper is transparent that this is a first attempt and invites community discussion (Section 3.6), which is appropriate for a benchmark methodology paper.

4. **Systematic head-to-head evaluation of 13 clocks across four tasks.** Table 1 and Figures 3E–F provide per-class and overall results, enabling concrete comparisons. The finding that second-generation clocks dominate the cumulative score while first-generation clocks excel at chronological-age prediction is consistent with known trade-offs and is usefully demonstrated on a standardized panel.

## Weaknesses

### Fatal
None.

### Major

1. **Lack of uncertainty quantification for the comparative rankings.** The benchmark scores, AA1/AA2 totals, and stated rankings (e.g., PhenoAgeV2 "becomes the most robust model" — Table 1) are all reported as point estimates without confidence intervals, bootstrap resampling, or leave-one-dataset-out sensitivity analysis. Because the dataset panel is a finite sample of 66 datasets across 19 conditions, the observed ordering could shift if the panel were re-sampled. The paper itself acknowledges (Section 5) that some datasets may be mis-evaluated due to covariate shift or small sample size, yet does not propagate this uncertainty into the reported rankings. For a contribution whose primary output is a *comparison* of clocks, this is a significant evidential gap. The framework itself is sound, but the evidence for the specific comparative conclusions is incomplete without some measure of ranking robustness.

### Minor

2. **Normality assumption of the statistical tests is stated but not validated.** The one-sided t-tests used in AA1 and AA2 are justified by "the assumption of normal distribution of Δ, a fundamental trait of the multivariate linear regression models commonly used in aging clock construction" (Section 3.5). However, no diagnostic check or sensitivity analysis with non-parametric alternatives (e.g., Mann-Whitney U for AA2, Wilcoxon signed-rank for AA1) is provided. For small datasets (minimum 5 AAC samples), deviations from normality could inflate false-positive rates.

3. **Missing-data imputation is not characterized.** The paper imputes missing CpG beta values using "gold standard" means from SeSAMe (Section 3.4) but does not report missingness rates per clock (each clock uses a different CpG set) or per dataset. If a clock's CpGs have high missingness specifically in AAC samples, imputation could systematically affect Δ estimates. A sensitivity analysis comparing a subset of complete cases to the imputed results would strengthen confidence in the reported scores.

4. **The cumulative score is acknowledged as ad hoc.** The paper states that "there could be a more optimal solution for the metric" and invites community discussion (Section 3.6). While honest, this limits the benchmark's conclusiveness as a definitive standardization tool: the score weights and functional form are chosen for simplicity rather than derived from any principled criterion (e.g., maximizing correlation with an external gold standard). This does not invalidate the contribution but should be noted when interpreting the leaderboard.

5. **Subjective language in the results section.** Phrases such as "two undeniable leaders" (Section 4) are used to describe clock rankings that lack quantitative uncertainty measures. This overstates the conclusiveness of the evidence and should be tempered with more measured language or supplemented with uncertainty estimates.

### Trivial
None.

## Nice-to-Haves

- **Bootstrap confidence intervals** for the cumulative score (resampling datasets, possibly stratified by condition class) and the per-task scores, plus the probability that each clock is genuinely the best.
- **Leave-one-condition-out sensitivity analysis** to test whether the overall ranking is driven by a single condition class (e.g., the immune system/HIV datasets, which dominate the ISD class).
- **Effect sizes** (e.g., Cohen's d or median difference in Δ between AAC and HC) in addition to p-values, to communicate practical magnitude beyond statistical significance.
- **Non-parametric test alternatives** as a sensitivity check for the AA1 and AA2 tasks (Mann-Whitney U / Wilcoxon signed-rank).
- **Missingness diagnostics**: the fraction of CpGs missing per clock in HC vs. AAC groups across datasets, and a comparison of imputed vs. complete-case results on a subset.
- **Covariate shift quantification**: a simple diagnostic (e.g., PCA on DNAm values) to contextualize the bias task results.

## Removed Points

These points were raised by reviewers but are removed or demoted after cross-checking against the paper:

- **"AA1 task's asymmetric bias penalty is unaddressed"** — The critic argued that the cumulative score penalizes only positive bias without justification. However, the paper explicitly states "We define cumulative benchmarking score such that it would account for the main drawback of AA1 task, namely, the sensitivity to *positive* model bias" (Section 3.6, emphasis added), providing a clear rationale: positive bias inflates AA1 scores (producing false positives), while negative bias deflates them (conservative). The critic's additional mathematical claim that "negative bias lowers the denominator Med(|Δ|), which actually increases the penalty coefficient" is factually incorrect — with max(0, Med(Δ))=0, the coefficient is 1 regardless of the denominator value. The paper's design choice is reasonable and justified. *Removed.*

- **"HIV may not meet the AAC criteria"** — The critic questioned whether HIV on modern ART has decreased life expectancy. The paper cites Table A2/A3 for population-based evidence supporting each condition's inclusion. Since the appendix (where this evidence resides) is part of the submission, this criticism speculates about content not available in the extracted main text but present in the full submission. *Removed per instruction: speculative criticism about appendix content.*

- **"Harmonization pipeline not described in main text"** — The paper states "see Section A.9 for details on data processing." The appendix is part of the full submission. *Removed per instruction about missing appendix content.*

- **"Code/data unavailable during review"** — The paper provides a Google Colab notebook and states that dataset references will be available after review. This is standard practice for double-blind review. *Removed per instruction about reproducibility nitpicks under double-blind constraints.*

- **"Reproducibility commitment" (strength)** — The paper promises code/data availability after review. This is a forward-looking commitment, not a demonstrated strength, and is standard for conference submissions. *Removed from strengths.*

- **Generic strengths** — The Strength Finder included "this paper addressed an important problem" framing, which is generic/superficial. The specific, evidence-grounded strengths are retained in the Strengths section above; generic restatements are removed.

## Novel Insights

The most valuable observation that emerges from the reviews is not about a weakness of the paper but about the design of the cumulative score: the asymmetric penalty for positive bias (max(0, Med(Δ))) is mathematically equivalent to saying "negative bias is self-correcting in the AA1 task because it makes the one-sided test harder to pass, so no statistical penalty is needed." Neither reviewer articulated this clearly — the critic saw it as a flaw, but it is actually a defensible design choice where the statistical test itself provides a natural correction for negative bias. This insight suggests that the paper's score design is more principled than the paper's own "ad hoc" characterization suggests.

## Suggestions

1. **Add bootstrap confidence intervals** for all scores and rankings. This is the single highest-leverage improvement: it would directly address the most significant weakness and substantially strengthen the paper's central comparative claims without changing the methodology.

2. **Add a sensitivity analysis with non-parametric tests** (Mann-Whitney U for AA2, Wilcoxon signed-rank for AA1) to verify that the reported p-values are not driven by normality violations in small datasets.

3. **Report missingness rates** and a brief sensitivity analysis (e.g., comparing results with and without imputation on a subset of datasets with low missingness) to rule out imputation artifacts.

4. **Tone down subjective language** ("undeniable leaders," "indisputable") or pair such claims with quantitative uncertainty bounds.

## Score and Decision

MY FINAL SCORE: <score>7.0</score>
MY FINAL DECISION: <decision>Accept</decision>